In Vivo Measurement of Human Skin Penetration: Alternatives for Measurement of Cutaneous Bioavailability

Dr. Betsy Hughes Formella of Bioskin GmbH explains why the development and validation of appropriate methodologies to determine the rate and extent to which a topically applied drug reaches its site of action within the skin is one of the biggest challenges in dermatological research today.